What the research found by the numbers Here are the specific, quantitative results the studies below produced
Research in earlier phases or small trials include evaluation of GLP-1s for cystic fibrosis-related diabetes, polycystic ovarian syndrome (PCOS), chronic obstructive pulmonary disease (COPD), Prader-Willi syndrome (PWS), asthma, substance or alcohol use disorder, and as add-on to insulin for type 1 diabetes (T1DM)
Epithalon not only decelerates aging, it also suppresses development of breast adenocarcinomas in transgenic Her-2/neu mice
Advanced Delivery: As discussed, look for liposomal technology
However, when combined with GLP-1s, it could help reduce this kind of food noise by decreasing hunger signals and increasing satiety